W. Cullmann

1.0k total citations
74 papers, 804 citations indexed

About

W. Cullmann is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, W. Cullmann has authored 74 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Medicine, 36 papers in Pharmacology and 22 papers in Molecular Biology. Recurrent topics in W. Cullmann's work include Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers) and Pneumonia and Respiratory Infections (12 papers). W. Cullmann is often cited by papers focused on Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers) and Pneumonia and Respiratory Infections (12 papers). W. Cullmann collaborates with scholars based in Germany, Switzerland and United Kingdom. W. Cullmann's co-authors include Wolfgang R. Dick, W. Opferkuch, Hermann Leying, A. Dalhoff, D. Elhardt, Heinrich Urwyler, Sebastian Wendt, M. Edelmann, J. J. C. Scheffer and Wolfgang König and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

W. Cullmann

63 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Cullmann Germany 15 543 357 192 187 141 74 804
Giovanni Bonfiglio Italy 18 433 0.8× 252 0.7× 205 1.1× 196 1.0× 200 1.4× 41 807
Axel Dalhoff Germany 13 348 0.6× 250 0.7× 201 1.0× 248 1.3× 77 0.5× 24 780
Anna Di Popolo Italy 19 609 1.1× 289 0.8× 335 1.7× 165 0.9× 363 2.6× 22 1.2k
Eliana S. Armstrong United States 12 509 0.9× 292 0.8× 238 1.2× 160 0.9× 81 0.6× 17 722
M. Michéa-Hamzehpour Switzerland 10 335 0.6× 216 0.6× 214 1.1× 106 0.6× 50 0.4× 18 554
Minjun Chen China 11 413 0.8× 161 0.5× 212 1.1× 113 0.6× 141 1.0× 28 696
Jason Thresher United States 12 656 1.2× 406 1.1× 258 1.3× 275 1.5× 105 0.7× 19 892
Patrick Plésiat France 13 685 1.3× 214 0.6× 333 1.7× 122 0.7× 200 1.4× 17 864
A. Briales Spain 15 583 1.1× 225 0.6× 232 1.2× 155 0.8× 168 1.2× 16 742
Catherine Llanes France 11 686 1.3× 191 0.5× 426 2.2× 103 0.6× 232 1.6× 12 875

Countries citing papers authored by W. Cullmann

Since Specialization
Citations

This map shows the geographic impact of W. Cullmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Cullmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Cullmann more than expected).

Fields of papers citing papers by W. Cullmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Cullmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Cullmann. The network helps show where W. Cullmann may publish in the future.

Co-authorship network of co-authors of W. Cullmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Cullmann. A scholar is included among the top collaborators of W. Cullmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Cullmann. W. Cullmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cullmann, W.. (2015). Mode of Action and Development of Resistance to Quinolones. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 42. 287–300.
2.
Cullmann, W.. (2015). Microbiology of Oral Cephalosporins. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 47. 72–109.
3.
Cullmann, W.. (1997). Moraxella catarrhalis: Virulenz- und resistenzmechanismen. Medizinische Klinik. 92(3). 162–166. 4 indexed citations
4.
Cullmann, W., et al.. (1993). Therapy of soft tissue infections with piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy. 31(suppl A). 105–112. 31 indexed citations
5.
Cullmann, W.. (1993). Importance of Beta-Lactamase Stability in Treating Today’s Respiratory Tract Infections. Respiration. 60(1). 10–15. 5 indexed citations
6.
Cullmann, W.. (1993). Survey of Antimicrobial Resistance to Oral Antibiotics in Italy. Chemotherapy. 39(1). 13–21. 4 indexed citations
7.
Scheffer, J. J. C., J. Knöller, W. Cullmann, & Wolfgang König. (1992). Effects of cefaclor, cefetamet and Ro 40–6890 on inflammatory responses of human granulocytes. Journal of Antimicrobial Chemotherapy. 30(1). 57–66. 15 indexed citations
8.
Cullmann, W., et al.. (1992). Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. International Journal of Antimicrobial Agents. 1(4). 175–191. 18 indexed citations
9.
Cullmann, W., et al.. (1992). Influence of Exogenous Factors and Antibiotics on the Cytoplasmic Membrane Proteins of <i>Staphylococcus aureus</i>. Chemotherapy. 38(4). 211–217. 2 indexed citations
10.
Leying, Hermann, et al.. (1991). Imipenem Resistance in <i>Acinetobacter baumanii</i> Is Due to Altered Penicillin-Binding Proteins. Chemotherapy. 37(6). 405–412. 119 indexed citations
11.
Cullmann, W.. (1991). Beta-Lactamase Inhibitors: Relation Between Kinetic Data and in-vitro Synergism Studies. Zentralblatt für Bakteriologie. 275(4). 500–503. 1 indexed citations
12.
Leying, Hermann, W. Cullmann, & Wolfgang R. Dick. (1991). Carbapenem Resistance in <i>Enterobacter aerogenes</i> is due to Lipopolysaccharide Alterations. Chemotherapy. 37(2). 106–113. 20 indexed citations
13.
Cullmann, W., et al.. (1990). Antibacterial Activity of Piperacillin and Tazobactam against Beta-Lactamase-Producing Clinical Isolates. Chemotherapy. 36(5). 356–364. 7 indexed citations
14.
Leying, Hermann, et al.. (1990). Role of the Outer Membrane for Quinolone Resistance in Enterobacteria. Chemotherapy. 36(1). 13–23. 14 indexed citations
15.
Cullmann, W.. (1990). Interaction of β-Lactamase Inhibitors with Various β-Lactamases. Chemotherapy. 36(3). 200–208. 8 indexed citations
16.
Cullmann, W.. (1990). [Causes of quinolone resistance in gram-negative bacteria].. PubMed. 18(3). 80–8. 1 indexed citations
17.
Cullmann, W. & Wolfgang R. Dick. (1990). Heterogeneity of Beta-Lactamase Production in Pseudomonas maltophilia, a Nosocomial Pathogen. Chemotherapy. 36(2). 117–126. 21 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Bonfiglio Breakdown of academic impact, for papers by Axel Dalhoff Breakdown of academic impact, for papers by Anna Di Popolo Breakdown of academic impact, for papers by Eliana S. Armstrong Breakdown of academic impact, for papers by M. Michéa-Hamzehpour Breakdown of academic impact, for papers by Minjun Chen Breakdown of academic impact, for papers by Jason Thresher Breakdown of academic impact, for papers by Patrick Plésiat Breakdown of academic impact, for papers by A. Briales Breakdown of academic impact, for papers by Catherine Llanes
Rankless by CCL
2026